We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.78B
AUM Growth
+$1.86B
Cap. Flow
+$1.52B
Cap. Flow %
26.37%
Top 10 Hldgs %
27.07%
Holding
7,146
New
1,119
Increased
2,707
Reduced
2,319
Closed
676

Sector Composition

Rank Sector Weight
1 Technology 25.28%
2 Consumer Discretionary 10.53%
3 Financials 9.98%
4 Healthcare 8.97%
5 Communication Services 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMDX icon
2926
Transmedics
TMDX
$3.07B
$41K ﹤0.01%
2,182
+1,776
+437% +$44.5K
TNYA icon
2927
Tenaya Therapeutics
TNYA
$163M
$41K ﹤0.01%
2,144
+1,665
+348% +$36.3K
UTMD icon
2928
Utah Medical Products
UTMD
$226M
$41K ﹤0.01%
403
+222
+123% +$22.7K
HLTH
2929
DELISTED
Cue Health Inc. Common Stock
HLTH
$41K ﹤0.01%
3,024
+2,995
+10,328% +$32.9K
BBIG
2930
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
$41K ﹤0.01%
1,267
-358
-22% -$21K
PCSB
2931
DELISTED
PCSB Financial Corporation
PCSB
$41K ﹤0.01%
2,159
+1,641
+317% +$30.7K
ZNTE
2932
DELISTED
Zanite Acquisition Corp. Class A Common Stock
ZNTE
$41K ﹤0.01%
4,049
+3,810
+1,594% +$38.7K
BTAQ
2933
DELISTED
Burgundy Technology Acquisition Corporation Class A Ordinary shares
BTAQ
$41K ﹤0.01%
4,038
+1,970
+95% +$19.6K
LJPC
2934
DELISTED
La Jolla Pharmaceutical Company
LJPC
$41K ﹤0.01%
8,752
+3,420
+64% +$14.3K
APLE icon
2935
Apple Hospitality REIT
APLE
$3.79B
$40K ﹤0.01%
2,458
-6,182
-72% -$97.8K
ATEX icon
2936
Anterix
ATEX
$1.79B
$40K ﹤0.01%
688
+276
+67% +$16.8K
AXSM icon
2937
Axsome Therapeutics
AXSM
$11.2B
$40K ﹤0.01%
1,051
-644
-38% -$23.7K
BBSI icon
2938
Barrett Business Services
BBSI
$781M
$40K ﹤0.01%
2,324
+1,328
+133% +$25.2K
COUR icon
2939
Coursera
COUR
$1.53B
$40K ﹤0.01%
1,629
-14,693
-90% -$447K
CRBU icon
2940
Caribou Biosciences
CRBU
$169M
$40K ﹤0.01%
2,660
+2,190
+466% +$42.6K
CXDO icon
2941
Crexendo
CXDO
$221M
$40K ﹤0.01%
8,098
+5,605
+225% +$30.2K
ESE icon
2942
ESCO Technologies
ESE
$7.92B
$40K ﹤0.01%
443
-589
-57% -$50.9K
EVER icon
2943
EverQuote
EVER
$861M
$40K ﹤0.01%
2,566
-1,167
-31% -$17.8K
FEZ icon
2944
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.56B
$40K ﹤0.01%
860
-432
-33% -$20.2K
ILF icon
2945
iShares Latin America 40 ETF
ILF
$3.71B
$40K ﹤0.01%
1,715
+1,481
+633% +$37K
KRP icon
2946
Kimbell Royalty Partners
KRP
$1.52B
$40K ﹤0.01%
+2,929
New +$41.9K
NCNA
2947
NuCana
NCNA
$6.62M
$40K ﹤0.01%
+3
New +$37.7K
OM icon
2948
Outset Medical
OM
$84.8M
$40K ﹤0.01%
59
-179
-75% -$132K
SENEB
2949
Seneca Foods Class B
SENEB
$1.28B
$40K ﹤0.01%
821
+305
+59% +$14.8K
SPR
2950
DELISTED
Spirit AeroSystems
SPR
$40K ﹤0.01%
938
-888
-49% -$38K

Similar funds

Tower Research Capital (TRC)'s Q4 2021 Portfolio in Review

As of Q4 2021, Tower Research Capital (TRC) held 7,146 positions worth $5.78B, up 48% from $3.92B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $1.52B of net new capital in Q4 2021, opening 1,119 new positions and adding to 2,707 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $404M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2021 buy was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2021, an estimated $125M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $404M.
  • Tower Research Capital (TRC) fully exited State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2021, selling an estimated $36.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $5.78B portfolio in Q4 2021.
  • Tower Research Capital (TRC) opened 1,119 new positions and closed 676 in Q4 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $5.78B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2021, filed 14 Feb 2022.